Resource Centers
- Sulfasalazine for Rheumatoid Arthritis May Cause Severe Hepatotoxicity
- Height Loss Measurement Improves Sensitivity of Osteoporosis Diagnosis
- Abatacept Shows Ongoing Benefit in Arthritis Patients
- Recalls & Warnings Etanercept Gets Black Box Warning for TB Risk
- FDA Safety Changes: Janumet, WelChol, Rituxan
- Guidelines Issued for Screening Men for Osteoporosis
Rheumatology Journals
Medscape Community Resources
POLL
According to a recent poll in Nature of 1400 academic scientists (70% from the United States), 20% reported nonmedical use of cognitive performance–enhancing drugs such as Ritalin, Provigil, and Inderal. Do you think a similar problem exists or does not exist among clinicians?
Rheumatology CME
- Fibromyalgia: Real-life Clinical Challenges
- Managing Joint Pain and Swelling in Primary Care: A Patient Simulation Series for the Healthcare Team
- Educating the Health Professional for Improving Cultural Competency
- Marrying Rheumatoid Arthritis Pathophysiology to Treatment Mechanism of Action: A Focus on New Therapies
- Drug Mix-Ups Threaten Patient Safety
Advisory Board
- Stanley B. Cohen, MD
- Robert I. Fox, MD, PhD
- Arthur Kavanaugh, MD
- Stephen A. Paget, MD, FACP, FACR
- Lee S. Simon, MD
Editorial Director
